Danaher Corporation

NYSE:DHR

Medical - Diagnostics & Research

Healthcare
$228.41 -0.21%

-$0.38 today

Market cap
$160.69B
Beta
0.83
P/E (TTM)
34.0
EPS (TTM)
$5.21
Dividend yield
0.77%
52W Low $160.93High $242.80

Volume 2.92M

Average 4.52M

News

For Danaher Corporation, read summarized stories built from several publishers and recent headlines with links to the original coverage.

Strategy & Operations

Danaher Outlines Growth Strategy Centered on Acquisitions, AI and Diagnostics

Danaher Corporation is concentrating on commercial execution, innovation and acquisitions as it pursues faster core growth and market-share gains, a company leader said during a conference discussion. The executive, identified in the transcript only by the first name Julie, also pointed to artificial intelligence and the company's diagnostics business as part of the push.

According to the executive, the company is working to make its dealings with customers simpler. The remarks came in a conversation with Tycho Peterson of the Life Science team at the Jefferies Global Healthcare Conference 2026.

The strategy update follows a fiscal 2025 in which Danaher reported revenue of 24.57 billion USD and net income of 3.61 billion USD. Analysts expect earnings of 2.49 USD per share on revenue of 7.49 billion USD for the quarter, with results due Jan 27, 2027.

More headlines

Recent coverage that has not been summarized. Links open the publisher's site.